Transcriptome-guided GLP-1 receptor therapy rescues metabolic and behavioral disruptions in a Bardet-Biedl Syndrome mouse model
RNA-seq (gene expression) · mouse · 10 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 10 samples: 3 × Bbs5_12 wks_mut_B vs 3 × Bbs5_5 wks_mut_E vs 2 × WT_B vs 2 × WT_EGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE293590_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1245329. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 10 samples.
How we read this: 4 replicated groups read from 10 sample titles; they account for 10 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8885988 WT_B1 WT_B
- GSM8885989 WT_B3 WT_B
- GSM8885990 Bbs5_12 wks_mut_B4 Bbs5_12 wks_mut_B
- GSM8885991 Bbs5_12 wks_mut_B5 Bbs5_12 wks_mut_B
- GSM8885992 Bbs5_12 wks_mut_B6 Bbs5_12 wks_mut_B
- GSM8885994 WT_E1 WT_E
- GSM8885995 WT_E3 WT_E
- GSM8885996 Bbs5_5 wks_mut_E4 Bbs5_5 wks_mut_E
- GSM8885997 Bbs5_5 wks_mut_E5 Bbs5_5 wks_mut_E
- GSM8885998 Bbs5_5 wks_mut_E6 Bbs5_5 wks_mut_E
- GSE245728 GLP-1 directed NMDA receptor antagonism for obesity treatment 87 samples shares glp-1, receptor
- GSE244607 GLP-1 directed NMDA receptor antagonism for obesity treatment [I] 64 samples shares glp-1, receptor
- GSE245727 GLP-1 directed NMDA receptor antagonism for obesity treatment [II] 23 samples shares glp-1, receptor
- GSE291407 GLP-1 receptor agonism results in reduction in hepatic ethanol metabolism 8 samples shares glp-1, receptor
- GSE325222 The hepatoprotective benefits of semaglutide in MASH require the intrahepatic endothelial GLP-1 receptor 4 samples shares glp-1, receptor
- GSE280382 Functional and multi-omic aging rejuvenation with GLP-1R agonism [bulk RNA-seq] 620 samples shares glp-1
- GSE314029 An unimolecular GIPR:GLP-1R:PPAR , , quintuple agonist eliminates obesity and insulin resistance in mice. 159 samples shares glp-1
- GSE293291 GIPR-Ab/GLP-1 Peptide-antibody Conjugate Requires CNS GIPRs and GLP-1Rs to Engage Anorexigenic Circuitry for Additive Weight Loss in Obese Mice 60 samples shares glp-1
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.